Current cost
One comparable recurring total when it can be calculated, otherwise a clearly labeled package price or an explicit missing-price state.
Peptide Provider Hub applies consistent field definitions to provider-published information, preserves source context, and makes uncertainty visible. The directory is informational and does not publish qualitative scores, rankings, recommendations, or provider evaluations.
Scope
The fields are designed to make factual, provider-stated details easier to scan. They are not measures of clinical quality, product quality, approval status, safety, or suitability.
One comparable recurring total when it can be calculated, otherwise a clearly labeled package price or an explicit missing-price state.
Whether the provider states that an ongoing membership or subscription is required for the listed offer.
Prescription clinical, research use only, consumer product, or unresolved. Ranking eligibility is decided per offer, not inferred from a company name.
FDA-approved product access, compounded prescription, both, or unclear—kept separate from the four-class product label.
Provider-stated product options shown as catalog information, not dosing instructions or medical advice.
The documented interaction pathway, such as an online questionnaire, video or phone visit, hybrid review, or supplier storefront.
Introductory amounts, dose- or supply-specific variants, prepaid terms, extra fees, conflicts, and source links remain available in the expanded price details.
The source URL and the date on which the displayed detail was last checked.
Research-use-only, consumer, and unresolved offers remain discoverable but stay outside prescription-provider price rankings.
Whether a public batch report, example report, order-supplied document, testing claim, or no public document was found—without treating a COA as human-use approval.
Collection process
A numeric price is recorded only when a current provider-controlled source identifies the exact marketed product or variant and the amount together. Search snippets, third-party pages, and similar products do not qualify.
Each record keeps its source URL and checked date so readers can understand where the detail came from and how recent the review is.
Missing, conflicting, removed, or inaccessible prices are left out until they can be confirmed. Other product options with clear current prices can remain visible.
Every documented provider listing appears with its verification, availability, and last-checked context. Partial or conflicting evidence remains visible instead of being converted into a recommendation.
These rules are intentionally narrow. When the available provider material does not support a field, the directory shows the value as missing or unverified instead of estimating it.
Beta evidence note (August 18, 2026): dated field-level source records support all 74 provider ledgers. The separate reproducible crawl archive currently covers 6 providers and remains in progress; the beta does not claim that archive is complete.
Promotions are labeled “Available,” “None listed,” or “Unverified.” Known conditions and dates are preserved. A temporary promotion is not treated as the regular starting price unless it is clearly identified as such.
A price source must open the exact product page or current catalog surface that reproduced the amount. The checked date is a timestamp, not a freshness guarantee. If a later recheck cannot reproduce the value, the amount is removed from comparisons.
Comparisons default to the lowest knowable recurring total, including a required monthly subscription when both amounts are documented. Within each availability tier, missing prices appear last. This field-based sort is not a qualitative recommendation, paid placement, endorsement, or assessment of safety.
The public directory does not publish medical advice, dosage guidance, treatment or efficacy claims, safety evaluations, product-quality judgments, qualitative provider rankings, “best” lists, or purchasing flows. It may display provider claims about unapproved or investigational products, with the regulatory and evidence limitations kept visible. It also does not fill gaps with unsupported assumptions.
If a displayed detail appears outdated or incomplete, send the provider or supplier name, affected field, public source, and date observed. A submission enters review and does not guarantee publication.
Contact the editorial team